Australian’s first scale-up biomedical facility

Translational Manufacturing Institute

Latest Update - Funding Announced

What is TMI@TRI?

TMI@TRI is purpose-built scale-up and advanced manufacturing facility that will provide the means for start-up companies to move to the scale-up stage.

It enables them to manufacture scale-up product in clean rooms to support Australian clinical trials to take the product to market, while also providing practical training in advanced manufacturing; and a highly skilled workforce.

The TMI@TRI Edge

Advanced Research

TMI@TRI meets the demand for pipeline development of medtech companies in Australia


over $1 billion of overall economic and health benefits


Advances research commercialisation and development

Covid Resilience

COVID-19 has demonstrated the importance of having localised sovereign capability in the MedTech sector

Download the Project Brochure Download

About the Translational Manufacturing Institute

Despite the strengths of its science base, Australia has been less successful at translating research into clinical outcomes and commercial successes with the aim of improving greater health for the community within Australia and the world.

Find out how TMI@TRI can benefit Australia’s industry and community health.

Australia’s Advantage

View the Project Updates